PPT-"Prescribing Controlled Substances: Problematic Use of Opioids and Benzodiazepines in

Daryl Shorter MD Staff Psychiatrist Michael E DeBakey VA Medical Center March 2 2017 Objectives By the completion of the presentation learners will be able to 1 List risk factors for misuse diversion andor dependence upon opioid medications and benzodiazepines. Part 1 of a 3 Part Series. Chuck Klein, Ph.D.. GM/Director, Medication Management. Agenda. Defining EPCS. Legal Aspects of EPCS. Pharmacies. Requirements: OrderConnect. Requirements: Prescribers. Two-Factor Authentication. Prescriber and Agent Workflow. Part 3 of a 3 Part Series. Chuck Klein, Ph.D.. GM/Director, Medication Management. Agenda. Defining EPCS. Requirements: Prescribers. Workflow for Prescribers . Workflow for Agents. Identifying . indicators of good prescribing and problem use in . primary care. Nicola . Torrance. Research Fellow. Chronic Pain Research . Group. http. ://medicine.dundee.ac.uk/chronic-pain. . Adverse effects. for . Abuse . of . Controlled Substances . with . e-Prescribing . Dr. James L. Holly, CEO, Southeast Texas Medical Associates, LLP. Adjunct . Professor, . Family and Community Medicine UTHSCSA School of Medicine. Daryl Shorter, MD. Staff Psychiatrist. Michael E. . DeBakey. VA Medical Center. March 2, 2017. Objectives . - By the completion of the presentation, learners will be able to:. (1) List risk factors for misuse, diversion, and/or dependence upon opioid medications and benzodiazepines. Tracy Brooks, . PharmD. , BCPS, BCNSP. Assistant Professor of Pharmacy Practice. Member of PRMC’s Palliative Care Team. Member of Indiana RX Task Force. Objectives:. Pharmacists:. Review the terms “legitimate medical purpose” and “corresponding responsibility” as they apply to the use of opioid analgesics in the treatment of chronic pain.. Introduction. The use of benzodiazepines has grown over time and evidence has shown that long term use of these drugs has very little benefit with many risks involved. . Many providers are receiving new patients on benzodiazepines and are uncomfortable with managing their treatment regimen. Part 1 of a 3 Part Series. Chuck Klein, Ph.D.. GM/Director, Medication Management. Agenda. Defining EPCS. Legal Aspects of EPCS. Pharmacies. Requirements: OrderConnect. Requirements: Prescribers. Two-Factor Authentication. Alicia Craig-Rodriguez, DNP-c, MBA. , BSN, . RN. Florida State University. Cynthia Drew, MSN, ARNP. Presented to the 2015 FLANP Annual Meeting. August 8, 2015. Objectives. Demonstrate . Alicia Craig-Rodriguez, DNP-c, MBA. , BSN, . RN. Florida State University. Cynthia Drew, MSN, ARNP. Presented to the 2015 FLANP Annual Meeting. August 8, 2015. Objectives. Demonstrate . Protecting Your License and  Practice. Jose Mathew D.O MPH. Diplomate, American Board of PM&R, . Pain Medicine Subspecialty Certification. Disclaimer. The information contained in this presentation is provided for informational purposes only, and should not be construed as legal advice on any subject matter.. Page 19-2019Coming SoonCOHE EMERGINGBESTPRACTICESBarriers to Recovery Functional Recovery QuestionnaireFRQCurrentlybeing administeredofficialmeasurement to be determinedWhat it isThe Functional Recove ---------------------------------------------------------------------------------------------------------------------Drug Enforcement Administration Pharmacist146s Manual Timothy J Shea Acting Adminis Natalie Winter, MD. Pain Management CRMG. Disclosure. “Natalie Winter MD and all others in control of this CME activity, reported no relevant financial relationships that would create a conflict of interest for CME purposes.” .